Carbox OD 300mg Tablet
By Carbox OD
Rx
10 Tablet in a Strip

Composition
Oxcarbazepine(300mg)

Manufacturer - Micro Labs Ltd
27, RACE COURSE ROAD, BANGALORE-560 001, INDIA

Expires on or after
September, 2025

liver
Carbox OD 300mg Tablet should be used cautiously in individuals with severe liver disease. It might be necessary to adjust the dosage of Carbox OD 300mg Tablet in these cases. It is important to consult your healthcare provider for guidance. However, dose adjustment is typically not required for individuals with mild to moderate liver disease. If unsure about how to proceed with Carbox OD 300mg Tablet in relation to liver issues, always consult your doctor for personalized advice.

kidney
Carbox OD 300mg Tablet should be used carefully in patients with kidney disease. The dosage of this tablet may need to be adjusted. It is important to consult your doctor regarding the use of this medication if you have kidney issues.

alcohol
Carbox OD 300mg Tablet may lead to increased drowsiness when taken with alcohol. It is important to be cautious of this effect.

driving
Carbox OD 300mg Tablet can cause drowsiness, dizziness, blurred vision, and lack of muscle coordination, especially when starting or increasing the dose. This may impact your driving ability.

pregnancy
Carbox OD 300mg Tablet may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor before taking Carbox OD 300mg Tablet during pregnancy.

breastfeeding
Carbox OD 300mg Tablet is likely unsafe to use while breastfeeding, as it may pass into breastmilk and potentially harm the baby. It is recommended to monitor the baby for increased sleepiness and weight gain.
Habit Forming | No |
Chemical Class | Iminostilbene Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Sodium channel modulators (AED) |
₹74.28
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024